clinical considerations, 882 –886 diagnostic testing, 883 –884 evidences, 881 –882 goals of treatment, 881 hospital admission and disposition, 886 management, 884 –886 noninvasive end-tidal CO2 monitoring, 884 triage and initial assessment, 883 stroke/cerebrovascular accident causes, 889 t clinical assessment, 890 , 890 t clinical considerations, 889 –891 diagnostic testing, 890 evidences, 889 goals of treatment, 888 management, 890 –891 triage considerations, 890 Neurologic injuries, without fractures, 1212 Neuromuscular blocking agent (NMBA), 36 , 39 –40 , 39 t Neuromuscular disease, 1177 Neuropathies, 249 , 558 Neuropathy, 249 Neuropsychiatric symptoms, 1428 t Neurosurgical emergencies, 1382 –1390 AVM, in right corpus callosum, 1384 f brain, axial CT of, 1383 f brain, coronal CT of, 1384 f central nervous system infection, 1387 discitis/osteomyelitis, 1387 –1388 meningitis, 1387 , 1387 t spinal epidural abscess, 1388 emergency therapy, goals of, 1382 hydrocephalus, acute clinical pitfall, 1385 clinical recognition, 1385 diagnostic imaging, 1385 management, 1385 –1386